Sigma Labs Reports First Quarter 2018 Financial Results

Conference Call to Be Held Today at 4:30pm Eastern Time

SANTA FE, N.M., May 15, 2018 (GLOBE NEWSWIRE) — Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs,” “we,” “our” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced financial results for the three months ended March 31, 2018 and provided an overview of recent accomplishments.

First Quarter 2018 and Recent Business Highlights

  • May 2018 – Sigma Labs expanded its business development in Europe by hiring its first employee in Europe.
     
  • April 2018 – Sigma Labs completed a $1.0 Million private placement financing.
     
  • April 2018 – Sigma Labs participated in two significant industry events including The Additive Manufacturing Users Group (AMUG) Conference and Exhibition in St. Louis, MO (http://www.amug.com) and The Rapid 2018 Conference in Fort Worth, TX (http://www.rapid3devent.com).
     
  • March 2018 – Sigma Labs signed a cooperative research and development agreement with the National Institute of Standards and Technology to assess production yields of metal additive manufacturing using the Company’s PrintRite3D® technology.
     
  • March 2018 – Sigma Labs released Version 3.0.2 of its PrintRite3D INSPECT® In-Process Quality Assurance™ (IPQA®) software featuring Sigma Labs’ new and proprietary Thermal Energy Density™ (TED™) In Process Quality Metric™ (IPQM®), setting what the Company views as a new industry standard for quantitatively measuring melt pool and part quality.

“In the first quarter of 2018 we raised additional capital in order to increase our working capital and technology resources to both grow the company and develop closed loop control,” commented John Rice, Chairman and Interim CEO of Sigma Labs. “We continue to upgrade our products and services while working evermore closely with select 3D metal manufacturing customers to provide on-site proof of our PrintRite3D technology’s ability and value to raise quality and economic yields in their AM metal production runs.  Our company continues the process of evolving from an R&D company culture into a technology commercialization company, as I indicated in our letter to our shareholders in January of this year. I am proud of the progress we are making so far and look forward to continuing on this sometimes twisted road to commercialization and to our goal of profitability,” Mr. Rice concluded.

First Quarter 2018 Financial Results

During the three months ended March 31, 2018, we recognized revenue of $103,415, as compared to $114,523 in revenue recognized during the same period in 2017. 

Sigma’s operating expenses for the three months ended March 31, 2018 were $1,177,130 as compared to $1,159,494 for the same period in 2017. The most significant of these operating expenses is personnel costs, specifically the payroll and stock-based compensation components of personnel costs. Personnel costs were $560,179 for the three months ended March 31, 2018 and $577,842 for the same period in 2017 or 48% and 50% of total operating expenses for the period, respectively. Total payroll costs for the first three months of 2018 were $39,554 lower than in the same period in 2017, primarily due to a $50,000 bonus payment in 2017 to our Vice President of Business Development in connection with the satisfaction of performance milestones. Stock-based compensation was $21,890 higher in the first three months of 2018 compared to the same period in 2017.

Outside Services Fees incurred in the three months ended March 31, 2018 were $319,622 compared to $364,784 incurred during the same period in 2017.  Services in connection with our obligations as an SEC reporting company, the February 2017 public offering, and in preparation of the April 2018 sale of convertible preferred stock were the major components of the fees incurred in both periods. The net decrease in these fees in 2018 results primarily from the one-time $42,000 entry fee paid to NASDAQ in connection with our being listed on the NASDAQ Capital Market in the first quarter of 2017.

Research and Development expenditures of $121,977 were incurred during the three months ended March 31, 2018 compared to $54,505 in the same period of 2017. This $67,472 increase resulted primarily from the purchase of multiple upgraded servers and various pieces of specialized equipment as part of our continued concentrated acceleration of technology development in 2018.

Sigma’s net loss for the three months ended March 31, 2018 totaled $1,170,876, as compared to $943,965 for the same period of 2017, a $226,911 increase.  The 2018 net operating loss contributed $63,684 to the overall loss increase, and other income and expenses contributed to the balance.

Investor Conference Call

Management will host a conference call on Tuesday, May 15, 2018 at 4:30pm to review financial results and corporate highlights. Following management’s formal remarks, there will be a question and answer session. To listen to the call by phone, interested parties within the U.S. should call 1-844-802-2441 and International callers should call 1-412-317-5134. All callers should ask for the Sigma Labs conference call. The conference call will also be available through a live webcast at www.sigmalabsinc.com. Details for the webcast may be found on the Company’s IR events page at:  http://client.irwebkit.com/sigmalabsinc/events.

A replay of the call will be available approximately one hour after the end of the call through June 15, 2018. The replay can be accessed via Sigma Labs’ website or by dialing 877-344-7529 (domestic) or 412-317-0088 (international) or Canada Toll Free at 855-669-9658. The replay conference ID number is 10120280. The webcast replay will be available through August 15, 2018.

About Sigma Labs, Inc.
Sigma Labs, Inc. is a provider of quality assurance software under the PrintRite3D® brand and a developer of advanced, in-process, non-destructive quality assurance software for commercial firms worldwide seeking productive solutions for advanced manufacturing. For more information please visit us at www.sigmalabsinc.com

Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Annual Report on Form 10-K (including but not limited to the discussion under “Risk Factors” therein) filed with the SEC on April 17, 2018 and which may be viewed at http://www.sec.gov.

Investor Relations Contact:
Bret Shapiro
Managing Director
CORE IR
561-479-8566
brets@coreir.com

 
Sigma Labs, Inc.
Condensed Balance Sheets
 
    March 31, 2018     December 31, 2017  
    (Unaudited)        
ASSETS                
Current Assets:                
Cash   $ 1,347,319     $ 1,515,674  
Accounts Receivable, net     72,195       104,538  
Note Receivable, net     266,062       788,500  
Inventory     116,381       192,705  
Prepaid Assets     57,216       55,278  
Total Current Assets     1,859,173       2,656,695  
                 
Other Assets:                
Property and Equipment, net     381,212       411,643  
Intangible Assets, net     296,880       294,396  
Investment in Joint Venture     500       500  
Prepaid Stock Compensation     50,359       31,576  
Total Other Assets     728,951       738,115  
                 
TOTAL ASSETS   $ 2,588,124     $ 3,394,810  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY                
                 
Current Liabilities:                
Accounts Payable   $ 265,814     $ 100,884  
Notes Payable     100,000       100,000  
Deferred Revenue     60,031       35,680  
Accrued Expenses     140,934       146,330  
Total Current Liabilities     566,779       382,894  
                 
                 
TOTAL LIABILITIES     566,779       382,894  
                 
Commitments & Contingencies                
                 
Stockholders’ Equity                
Preferred Stock, $0.001 par; 10,000,000 shares authorized; None issued and outstanding            
Common Stock, $0.001 par; 15,000,000 shares authorized; 5,002,185 and 4,978,929 issued and outstanding, respectively     5,002       4,979  
Additional Paid-In Capital     17,525,689       17,345,407  
Accumulated Deficit     (15,509,346 )     (14,338,470 )
Total Stockholders’ Equity     2,021,345       3,011,916  
                 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   $ 2,588,124     $ 3,394,810  
 

 
Sigma Labs, Inc.
Condensed Statements of Operations
(Unaudited)
 
    Three Months Ended  
    March 31, 2018     March 31, 2017  
             
REVENUES   $ 103,415     $ 114,523  
                 
COST OF REVENUE     73,795       74,534  
                 
GROSS PROFIT     29,620       39,989  
                 
OPERATING EXPENSES:                
Salaries & Benefits     398,657       438,210  
Stock-Based Compensation     161,522       139,632  
Operating R&D Costs     121,977       54,505  
Investor & Public Relations     180,399       265,146  
Legal & Professional Service Fees     138,423       99,638  
Office Expenses     95,106       84,205  
Depreciation & Amortization     47,321       46,148  
Other Operating Expenses     33,725       32,010  
Total Operating Expenses     1,177,130       1,159,494  
                 
INCOME FROM OPERATIONS     (1,147,510     (1,119,505
                 
OTHER INCOME (EXPENSE)                
Interest Income     13,167       343  
State Incentives           152,068  
Change in fair value of derivative liabilities           93,206  
Interest Expense           (49,316 )
Debt discount amortization           (56,441 )
Loss on Disposal of Assets     (36,733 )      
Total Other Income (Expense)     (23,366 )     139,860  
                 
LOSS BEFORE PROVISION FOR INCOME TAXES     (1,170,876 )     (979,645 )
                 
Provision for Income Taxes            
                 
Net Loss   $ (1,170,876 )   $ (979,645 )
                 
Net Loss per Common Share – Basic and Diluted   $ (0.23 )   $ (0.26 )
                 
Weighted Average Number of Shares Outstanding – Basic and Diluted     4,997,534       3,835,875  
 

 
Sigma Labs, Inc.
Condensed Statements of Cash Flows
(Unaudited)
 
    Three Months Ended  
    March 31, 2018     March 31, 2017  
OPERATING ACTIVITIES                
Net Loss   $ (1,170,876 )   $ (979,645 )
Adjustments to reconcile Net Loss to Net Cash used in operating activities:                
Noncash Expenses:                
Depreciation and Amortization     47,320       46,149  
Stock Based Compensation     161,522       140,671  
Loss on Write-off of Asset     36,733        
Gain/Loss on Change in Derivative Balance           (93,206 )
Original Issue Discount Amortization           24,658  
Debt Discount Amortization           56,441  
Change in assets and liabilities:                
Accounts Receivable     32,343       130,882  
Interest Receivable     22,438        
Inventory     76,324       (13,732 )
Prepaid Assets     (1,938 )     7,039  
Accounts Payable     164,930       167,845  
Deferred Revenue     24,351       35,680  
Accrued Expenses     (5,396 )     36,665  
NET CASH USED IN OPERATING ACTIVITIES     (612,249 )     (440,553 )
                 
INVESTING ACTIVITIES                
Purchase of Property and Equipment     (16,565 )     (33,000 )
Purchase of Intangible Assets     (39,542 )     (17,441 )
Advance of Funds for Note Receivable             (500,000 )
Proceeds from Note Receivable and Related Accrued Interest     500,000        
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES     443,894       (550,441 )
                 
FINANCING ACTIVITIES                
Gross Proceeds from issuance of Common Stock and Warrants           5,823,300  
Offering Costs Paid           (597,651 )
NET CASH PROVIDED BY FINANCING ACTIVITIES           5,225,649  
                 
NET CHANGE IN CASH FOR PERIOD     (168,355 )     4,234,655  
                 
CASH AT BEGINNING OF PERIOD     1,515,674       398,391  
                 
CASH AT END OF PERIOD   $ 1,347,319     $ 4,633,046  
                 
Supplemental Disclosures:                
Other noncash operating activities disclosure:                
Issuance of Common Stock for services   $ 40,000     $ 51,408  
Disclosure of cash paid for:                
Interest   $     $ 20,114  
Income Taxes   $     $